Blog - Page 4314 of 5436

ThursdayJul 24, 2008 5:26 am

Preventive Medicine for Your Stock Portfolio – Mid-Week Management Mantra

A prominent television business channel scoffs at the thought of asking a doctor for stock advice. That is the provocation for this post. Doctors may not be commerce majors, but diagnosis is right up their collective street. A physician is trained to smell impending disease when a patient feels fit and fine. It is not enough for executives to proclaim that your stocks in their care have done well. It is Freddie (NYSE: FRE) today. Who knows if your Fannie (NYSE: FNM) could be in pain tomorrow? Here are five reliable stethoscopes to find out which stock beats to skip:…

ThursdayJul 24, 2008 4:50 am

MEMC Electronic Materials, Inc. (MEMC) Reports Disappointing Earnings for the Second Quarter, Lowers FY08 Guidance

MEMC Electronic Materials, Inc. (WFR), a leading provider of polysilicon wafers to the solar cell manufacturing and semiconductor industries, reported second quarter results yesterday that fell short of analysts’ expectations. Revenues increased 12.4% year-over-year to $531.4 million vs. analysts’ estimates of $616.3 million. Net income on a non-GAAP basis was $212 million or 92 cents per share vs. $1.14 per share consensus. The company continues to be plagued by problems that negatively impact production. A fire at their Pasadena, Texas facility caused a weeklong shutdown, and a faulty heat exchanger at their Merano, Italy facility reduced polysilicon output by five…

ThursdayJul 24, 2008 4:27 am

Potash Corp. (POT) Reports 220% Increase in Second Quarter Net Income, Raises FY08 Guidance Yet Again

Potash Corporation of Saskatchewan Inc. (POT), Canada’s largest fertilizer company specializing in potash, phosphate and nitrogen products, reported better than expected second quarter results this morning. Revenues nearly doubled year-over-year to $2.62 billion vs. analysts’ estimates of $2.55 billion. Net income surged 220% to $905.1 million, or $2.82 per diluted share. Analysts were expecting earnings of $2.61 per share. "This quarter established a new standard of performance for our company," said PotashCorp President and Chief Executive Officer Bill Doyle. "We are experiencing strong growth in demand and are capturing the value of higher prices in all three nutrients, especially in…

WednesdayJul 23, 2008 5:15 pm

Dutton Associates Featured Company: Neurobiological Technologies, Inc. (NTII)

Neurobiological Technologies, Inc. (NASDAQ: NTII) is a biopharmaceutical company focused on developing innovative and leading agents for central nervous system conditions and other serious medical conditions. The company seeks out drug candidates related to the central nervous system, and develops therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer. They employ a strategy of in-licensing late-stage CNS agents and strive to gain regulatory approval and commercialization, either independently or with a strategic partner. Neurobiological Technologies most advanced product candidate is Viprinex™ (ancrod), a drug for treating acute ischemic stroke. The…

WednesdayJul 23, 2008 5:13 pm

Dutton Associates Featured Company: NexMed, Inc. (NEXM)

NexMed, Inc. (NASDAQ: NEXM) engages in producing innovative medical treatments by utilizing their proprietary NexACT® drug delivery technology. The company works with large pharmaceutical companies offering their NexACT® drug delivery technology to be incorporated into existing drugs, allowing these companies to save enormously on research and development costs while developing new patient-friendly products which extend patent life-spans and brand equity. NexMed has partnerships with Novartis International Pharmaceutical Ltd. for licensing and marketing Onychomycosis treatment, an anti-fungal drug, and a licensing agreement with Warner Chilcott, Ltd. for exclusive rights to their topically applied treatment for erectile dysfunction (ED). NexACT is the…

WednesdayJul 23, 2008 5:11 pm

Dutton Associates Featured Company: Patriot Scientific Corp. (PTSC.OB)

As a leading intellectual-property licensing company based out of Carlsbad, CA, Patriot Scientific Corporation engages in development and marketing, and supports innovative technologies that satisfy the demands of emerging markets for wireless devices, smart cards, home appliances, network gateways, entertainment technology, biomedical devices, and industrial controllers. Their key priority is to serve the world's industries through scientific innovation. Most of their focus is set on utilizing their resources to invest in discovering and licensing technologies that possess the potential to produce breakthrough solutions and advanced technology. A joint venture between Patriot Scientific and The TPL Group was established in 2005,…

WednesdayJul 23, 2008 5:05 pm

Enable IPC Corporation (EIPC.OB) Partners with Spain-Based Company in Effort to Develop Ultracapacitors

As a leading company converting breakthrough technologies into products and introducing them to the worldwide market, Enable IPC Corporation (OTCBB: EIPC) recently announced that they have partnered with Madrid, Spain-based IMDEA Energy Institute to combine their efforts in developing ultracapacitors based on Enable IPC's patent-pending energy technology. It has been confirmed by both companies that the initial project will be to incorporate Enable IPC's ultracapacitor into the SA2VE clean energy innovation program. Enable IPC's ultracapacitor technology combines nanoparticles with common carbon sheets that produce a low cost, easily implemented technology that ultimately improves the performance of ultracapacitors, which enables them…

WednesdayJul 23, 2008 5:04 pm

UAL Corporation (UAUA) Extends Agreements with Two Key Partners

UAL Corporation (NASDAQ: UAUA), a holding company whose primary subsidiary is United Airlines, announced that they have reached an agreement in principle that will extend the term of their respective agreements with their Mileage Plus co-branded bank card partner, Chase Bank U.S.A., N.A. (Chase), and Paymentech, one of their credit card processors. At the closing of Tuesday's public trading, the company's stock rose 68.54%. To be included in the transaction, United will receive a payment of $600 million from Chase, which relates to the advance purchase of frequent flyer miles and the extension of the contract. The company anticipates that…

WednesdayJul 23, 2008 5:02 pm

American Reprographics Company (ARP) Acquires Hudson Blueprint Company

American Reprographics Company (ARP) is a reprographics company that provides business-to-business document management services to the architectural, engineering and construction industry. Based in Walnut Creek, California, the company provides its services through a suite of self-owned reprographics technology products, a nationwide network of locally-branded reprographics service centers, and more than 4,000 facilities management programs at customers’ locations throughout the country. Service centers are connected digitally, thus allowing the company to provide service to more than 140,000 active customers nationally. The company has recently acquired the assets of Hudson Blueprint Company, the largest provider of reproduction, document management and related services…

WednesdayJul 23, 2008 3:21 pm

FluoroPharma, Inc. (FPMI) Reports Positive Phase I Safety Results for BFPET

FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging. BFPET is FluoroPharma’s second cardiovascular product to complete Phase I clinical development. BFPET is a PET imaging agent, designed to assess the blood flow in the heart (myocardial perfusion). Myocardial perfusion imaging is a standard test to assess coronary artery disease (CAD), with more than 9 million Americans undergoing the test annually. The Phase I trial, led by Principal Investigator Alan J. Fischman, MD, PhD at the Massachusetts…

Site Search

Company Search